Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Imagion Biosystems Limited
Health
Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| - | 18 Jan 2021 |
| - | 18 Jan 2021 |
| +8.00% | 21 Dec 2020 |
| +8.00% | 21 Dec 2020 |
| 0.00% | 16 Dec 2020 |
| -13.33% | 15 Dec 2020 |
| -13.33% | 15 Dec 2020 |
| -13.33% | 15 Dec 2020 |
| -10.71% | 07 Dec 2020 |
| +13.04% | 27 Nov 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,047
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Imagion Biosystems Limited (IBX) was incorporated on 6th December 2016. The Company's underlying business was founded in the United States. Shortly after its incorporation Imagion Biosystems Limited purchased all of the issued share capital in Imagion US from Manhattan Scientifics. The company's proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases and provide the ability to detect these cells using highly sensitive magnetic sensors.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:IBX is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia